GetTopicDetailResponse(id=a37ee551709, topicName=突變負擔, introduction=突變負擔, content=null, image=null, comments=4, allHits=1198, url=https://h5.medsci.cn/topic?id=75517, type=0, isShow=1, status=1, isAdmin=null, adminId=1, adminEncryptionId=1eae1, adminName=小M, createdBy=null, createdName=, createdAvatar=, createdTime=Fri May 29 21:19:53 CST 2020, time=2020-05-29, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=77645, tagList=[TagDto(tagId=77645, tagName=突變負擔)], ipAttribution=, topicAdmin=1, lengthMark=0)
[GetTopicListResponse(id=1864326, encodeId=53b41864326b0, content=<a href='/topic/show?id=a37ee551709' target=_blank style='color:#2F92EE;'>#突變負擔#</a>, objectTitle=Nat Med：血源性腫瘤突變負擔作為非小細胞肺癌阿特珠單抗治療的生物標志物, objectType=article, longId=724549, objectId=b40de24549be, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b40de24549be, replyNumber=0, likeNumber=92, createdTime=2022-11-22, rootId=0, userName=zutt, userId=742793, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b40de24549be, moduleTitle=Nat Med：血源性腫瘤突變負擔作為非小細胞肺癌阿特珠單抗治療的生物標志物, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=b40de24549be)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1864325, encodeId=51de18643258b, content=<a href='/topic/show?id=a37ee551709' target=_blank style='color:#2F92EE;'>#突變負擔#</a>, objectTitle=AJH：PD-L1 過表達與 JAK2-V617F 突變負擔相關，并與骨髓增殖性腫瘤中的 9p 單親二體性相關。, objectType=article, longId=293934, objectId=e987293934a7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e987293934a7, replyNumber=0, likeNumber=86, createdTime=2022-12-23, rootId=0, userName=zutt, userId=742793, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e987293934a7, moduleTitle=AJH：PD-L1 過表達與 JAK2-V617F 突變負擔相關，并與骨髓增殖性腫瘤中的 9p 單親二體性相關。, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=e987293934a7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1864324, encodeId=618e186432483, content=<a href='/topic/show?id=a37ee551709' target=_blank style='color:#2F92EE;'>#突變負擔#</a>, objectTitle=Lancet Gastroen Hepatol：多種突變負擔及其他分子標志物對結(jié)腸癌預后的影響, objectType=article, longId=142427, objectId=e55014242e8d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e55014242e8d, replyNumber=0, likeNumber=121, createdTime=2019-01-16, rootId=0, userName=zutt, userId=742793, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e55014242e8d, moduleTitle=Lancet Gastroen Hepatol：多種突變負擔及其他分子標志物對結(jié)腸癌預后的影響, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=e55014242e8d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1864323, encodeId=4bdc1864323b6, content=<a href='/topic/show?id=a37ee551709' target=_blank style='color:#2F92EE;'>#突變負擔#</a>, objectTitle=NEJM：納武單抗聯(lián)合易普利姆瑪可改善高突變負擔肺癌患者生存, objectType=article, longId=135592, objectId=71dd1355929f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=71dd1355929f, replyNumber=0, likeNumber=110, createdTime=2018-12-31, rootId=0, userName=zutt, userId=742793, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=71dd1355929f, moduleTitle=NEJM：納武單抗聯(lián)合易普利姆瑪可改善高突變負擔肺癌患者生存, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=71dd1355929f)], followStatus=false, userIsMember=false, type=1, lengthMark=0)]
梅斯話題小助手
2020-05-29
